412 related articles for article (PubMed ID: 34073629)
21. Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications.
Elazazy O; Midan HM; Shahin RK; Elesawy AE; Elballal MS; Sallam AM; Elbadry AMM; Elrebehy MA; Bhnsawy A; Doghish AS
Pathol Res Pract; 2023 Jun; 246():154512. PubMed ID: 37172525
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine.
Martinez-Prat L; Palterer B; Vitiello G; Parronchi P; Robinson WH; Mahler M
Expert Rev Clin Immunol; 2019 Oct; 15(10):1073-1087. PubMed ID: 31524005
[No Abstract] [Full Text] [Related]
23. [The pathogenic role of ACPA in rheumatoid arthritis].
Umeda N; Matsumoto I; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):391-395. PubMed ID: 29367523
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of long non-coding RNA PVT1 induces apoptosis of fibroblast-like synoviocytes through modulating miR-543-dependent SCUBE2 in rheumatoid arthritis.
Wang J; Kong X; Hu H; Shi S
J Orthop Surg Res; 2020 Apr; 15(1):142. PubMed ID: 32293498
[TBL] [Abstract][Full Text] [Related]
25. Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.
Shelef MA; Sokolove J; Lahey LJ; Wagner CA; Sackmann EK; Warner TF; Wang Y; Beebe DJ; Robinson WH; Huttenlocher A
Arthritis Rheumatol; 2014 Jun; 66(6):1482-91. PubMed ID: 24497204
[TBL] [Abstract][Full Text] [Related]
26. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
[TBL] [Abstract][Full Text] [Related]
27. The expression of mRNA for peptidylarginine deiminase type 2 and type 4 in bone marrow CD34+ cells in rheumatoid arthritis.
Nagai T; Matsueda Y; Tomita T; Yoshikawa H; Hirohata S
Clin Exp Rheumatol; 2018; 36(2):248-253. PubMed ID: 29148420
[TBL] [Abstract][Full Text] [Related]
28. Rheumatoid arthritis and non-coding RNAs; how to trigger inflammation.
Tofigh R; Hosseinpourfeizi M; Baradaran B; Teimourian S; Safaralizadeh R
Life Sci; 2023 Feb; 315():121367. PubMed ID: 36639050
[TBL] [Abstract][Full Text] [Related]
29. Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses.
Mergaert AM; Denny MF; Kingstad-Bakke B; Bawadekar M; Bashar SJ; Warner TF; Suresh M; Shelef MA
J Immunol Res; 2022; 2022():5258221. PubMed ID: 35083342
[TBL] [Abstract][Full Text] [Related]
30. Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies,
Guderud K; Mæhlen MT; Nordang GBN; Viken MK; Andreassen BK; Molberg Ø; Flåm ST; Lie BA
J Rheumatol; 2018 Aug; 45(9):1211-1219. PubMed ID: 29858238
[TBL] [Abstract][Full Text] [Related]
31. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
[TBL] [Abstract][Full Text] [Related]
32. Citrullinated proteins in rheumatoid arthritis.
Yamada R; Suzuki A; Chang X; Yamamoto K
Front Biosci; 2005 Jan; 10():54-64. PubMed ID: 15574347
[TBL] [Abstract][Full Text] [Related]
33. Combination of Two Monoclonal Anti-Citrullinated Protein Antibodies Induced Tenosynovitis, Pain, and Bone Loss in Mice in a Peptidyl Arginine Deiminase-4-Dependent Manner.
Krishnamurthy A; Circiumaru A; Sun J; Kisten Y; Damberg P; Sakuraba K; Sandor K; Jarvoll P; Zhou T; Malmström V; Svensson CI; Hensvold A; Catrina AI; Klareskog L; Réthi B
Arthritis Rheumatol; 2023 Feb; 75(2):164-170. PubMed ID: 35930718
[TBL] [Abstract][Full Text] [Related]
34. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
35. Contact with stimulated T cells up-regulates expression of peptidylarginine deiminase 2 and 4 by human monocytes.
Ferrari-Lacraz S; Sebbag M; Chicheportiche R; Foulquier C; Serre G; Dayer JM
Eur Cytokine Netw; 2012 Jun; 23(2):36-44. PubMed ID: 22614825
[TBL] [Abstract][Full Text] [Related]
36. The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis.
Yang J; Li Z; Wang L; Yun X; Zeng Y; Ng JPL; Lo H; Wang Y; Zhang K; Law BYK; Wong VKW
Pharmacol Res; 2022 Dec; 186():106549. PubMed ID: 36368452
[TBL] [Abstract][Full Text] [Related]
37. Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts.
Tsoyi K; Esposito AJ; Sun B; Bowen RG; Xiong K; Poli F; Cardenas R; Chu SG; Liang X; Ryter SW; Beeton C; Doyle TJ; Robertson MJ; Celada LJ; Romero F; El-Chemaly SY; Perrella MA; Ho IC; Rosas IO
Sci Rep; 2022 Feb; 12(1):2847. PubMed ID: 35181688
[TBL] [Abstract][Full Text] [Related]
38. LncRNAs expression in adjuvant-induced arthritis rats reveals the potential role of LncRNAs contributing to rheumatoid arthritis pathogenesis.
Jiang H; Qin XJ; Li WP; Ma R; Wang T; Li ZQ
Gene; 2016 Nov; 593(1):131-142. PubMed ID: 27511374
[TBL] [Abstract][Full Text] [Related]
39. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
40. Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non-coding RNAs in T cells.
Lai NS; Koo M; Yu CL; Lu MC
Clin Exp Immunol; 2017 Mar; 187(3):327-336. PubMed ID: 27880973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
